Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nystatin for oral irritation in IL-2 patients
NCT00001812Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in oral candidiasis and stomatitis comparing Nystatin with Placebo (2 arms). Primary endpoint: Rate of development of oral irritation. Started Apr 1999; status: completed.
02
Drugs
nystatin
03
Conditions
oral candidiasisstomatitis
Beyond the preview
Go deeper on NCT00001812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001812.